Full Text View
Tabular View
No Study Results Posted
Related Studies
Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia
This study is ongoing, but not recruiting participants.
Study NCT00047190   Information provided by National Cancer Institute (NCI)
First Received: October 3, 2002   Last Updated: July 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Metaplasia
Myelofibrosis
Myeloid Metaplasia
Myeloproliferative Disorders
More general conditions related to this trial
Bone Marrow Diseases
Hematologic Diseases
Lymphatic Diseases
Pathologic Processes
Splenic Diseases
Interventions listed in this trial
tipifarnib
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Mayo Clinic
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services